Review




Structured Review

Proteintech ifit 1
Ifit 1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 49 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ifit 1/product/Proteintech
Average 93 stars, based on 49 article reviews
ifit 1 - by Bioz Stars, 2026-05
93/100 stars

Images



Similar Products

99
ATCC thp 1 ifit 1
Thp 1 Ifit 1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/thp 1 ifit 1/product/ATCC
Average 99 stars, based on 1 article reviews
thp 1 ifit 1 - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

94
Novus Biologicals murine monoclonal antibody against ifit 1
Murine Monoclonal Antibody Against Ifit 1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/murine monoclonal antibody against ifit 1/product/Novus Biologicals
Average 94 stars, based on 1 article reviews
murine monoclonal antibody against ifit 1 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc rabbit monoclonal antibody against ifit 1
Rabbit Monoclonal Antibody Against Ifit 1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit monoclonal antibody against ifit 1/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
rabbit monoclonal antibody against ifit 1 - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

99
OriGene mouse anti ifit 1
Mouse Anti Ifit 1, supplied by OriGene, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti ifit 1/product/OriGene
Average 99 stars, based on 1 article reviews
mouse anti ifit 1 - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc endogenous ifit 1
Calu‐3 cells were incubated with the indicated amounts of type I IFN 24 h prior to infection with normalized amounts of SARS–CoV‐2 wt (WT) or Nsp16mut at 0.015 RNA copies/cell. Viral load in the supernatant was quantified at the indicated time points by RT–qPCR targeting viral polymerase RdRp. Results are plotted as mean of triplicate infections with error bars representing the SD (biological replicates). One out of three independent experiments is shown ( n = 3). Three days postinfection, protein expression <t>of</t> <t>IFIT1</t> was analyzed by immunoblot to control for type I IFN treatment. Membranes were probed with antibodies targeting IFIT1 and the housekeeping gene HSP90. Calu‐3 cells were incubated with medium (‐IFN) or 100 U/well type I IFN at the indicated time points prior‐ or postinfection. Cells were infected with normalized amounts of SARS–CoV‐2 wt (WT) or Nsp16mut at 0.015 RNA copies/cell. Viral load in the supernatant was quantified at 3 dpi by RT–qPCR targeting viral polymerase RdRp. Results are plotted as mean of triplicate infections with error bars representing the SD (biological replicates). One out of three independent experiments is shown ( n = 3). Data information: Statistical analysis was done using two‐way ANOVA followed by Bonferroni's multiple comparisons test. ns, not significant ( P > 0.05). Source data are available online for this figure.
Endogenous Ifit 1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/endogenous ifit 1/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
endogenous ifit 1 - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

93
Proteintech ifit 1
Calu‐3 cells were incubated with the indicated amounts of type I IFN 24 h prior to infection with normalized amounts of SARS–CoV‐2 wt (WT) or Nsp16mut at 0.015 RNA copies/cell. Viral load in the supernatant was quantified at the indicated time points by RT–qPCR targeting viral polymerase RdRp. Results are plotted as mean of triplicate infections with error bars representing the SD (biological replicates). One out of three independent experiments is shown ( n = 3). Three days postinfection, protein expression <t>of</t> <t>IFIT1</t> was analyzed by immunoblot to control for type I IFN treatment. Membranes were probed with antibodies targeting IFIT1 and the housekeeping gene HSP90. Calu‐3 cells were incubated with medium (‐IFN) or 100 U/well type I IFN at the indicated time points prior‐ or postinfection. Cells were infected with normalized amounts of SARS–CoV‐2 wt (WT) or Nsp16mut at 0.015 RNA copies/cell. Viral load in the supernatant was quantified at 3 dpi by RT–qPCR targeting viral polymerase RdRp. Results are plotted as mean of triplicate infections with error bars representing the SD (biological replicates). One out of three independent experiments is shown ( n = 3). Data information: Statistical analysis was done using two‐way ANOVA followed by Bonferroni's multiple comparisons test. ns, not significant ( P > 0.05). Source data are available online for this figure.
Ifit 1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ifit 1/product/Proteintech
Average 93 stars, based on 1 article reviews
ifit 1 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

94
Proteintech ifit 3
Calu‐3 cells were incubated with the indicated amounts of type I IFN 24 h prior to infection with normalized amounts of SARS–CoV‐2 wt (WT) or Nsp16mut at 0.015 RNA copies/cell. Viral load in the supernatant was quantified at the indicated time points by RT–qPCR targeting viral polymerase RdRp. Results are plotted as mean of triplicate infections with error bars representing the SD (biological replicates). One out of three independent experiments is shown ( n = 3). Three days postinfection, protein expression <t>of</t> <t>IFIT1</t> was analyzed by immunoblot to control for type I IFN treatment. Membranes were probed with antibodies targeting IFIT1 and the housekeeping gene HSP90. Calu‐3 cells were incubated with medium (‐IFN) or 100 U/well type I IFN at the indicated time points prior‐ or postinfection. Cells were infected with normalized amounts of SARS–CoV‐2 wt (WT) or Nsp16mut at 0.015 RNA copies/cell. Viral load in the supernatant was quantified at 3 dpi by RT–qPCR targeting viral polymerase RdRp. Results are plotted as mean of triplicate infections with error bars representing the SD (biological replicates). One out of three independent experiments is shown ( n = 3). Data information: Statistical analysis was done using two‐way ANOVA followed by Bonferroni's multiple comparisons test. ns, not significant ( P > 0.05). Source data are available online for this figure.
Ifit 3, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ifit 3/product/Proteintech
Average 94 stars, based on 1 article reviews
ifit 3 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

92
Novus Biologicals ifit 1 antibody
Calu‐3 cells were incubated with the indicated amounts of type I IFN 24 h prior to infection with normalized amounts of SARS–CoV‐2 wt (WT) or Nsp16mut at 0.015 RNA copies/cell. Viral load in the supernatant was quantified at the indicated time points by RT–qPCR targeting viral polymerase RdRp. Results are plotted as mean of triplicate infections with error bars representing the SD (biological replicates). One out of three independent experiments is shown ( n = 3). Three days postinfection, protein expression <t>of</t> <t>IFIT1</t> was analyzed by immunoblot to control for type I IFN treatment. Membranes were probed with antibodies targeting IFIT1 and the housekeeping gene HSP90. Calu‐3 cells were incubated with medium (‐IFN) or 100 U/well type I IFN at the indicated time points prior‐ or postinfection. Cells were infected with normalized amounts of SARS–CoV‐2 wt (WT) or Nsp16mut at 0.015 RNA copies/cell. Viral load in the supernatant was quantified at 3 dpi by RT–qPCR targeting viral polymerase RdRp. Results are plotted as mean of triplicate infections with error bars representing the SD (biological replicates). One out of three independent experiments is shown ( n = 3). Data information: Statistical analysis was done using two‐way ANOVA followed by Bonferroni's multiple comparisons test. ns, not significant ( P > 0.05). Source data are available online for this figure.
Ifit 1 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ifit 1 antibody/product/Novus Biologicals
Average 92 stars, based on 1 article reviews
ifit 1 antibody - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

Image Search Results


Calu‐3 cells were incubated with the indicated amounts of type I IFN 24 h prior to infection with normalized amounts of SARS–CoV‐2 wt (WT) or Nsp16mut at 0.015 RNA copies/cell. Viral load in the supernatant was quantified at the indicated time points by RT–qPCR targeting viral polymerase RdRp. Results are plotted as mean of triplicate infections with error bars representing the SD (biological replicates). One out of three independent experiments is shown ( n = 3). Three days postinfection, protein expression of IFIT1 was analyzed by immunoblot to control for type I IFN treatment. Membranes were probed with antibodies targeting IFIT1 and the housekeeping gene HSP90. Calu‐3 cells were incubated with medium (‐IFN) or 100 U/well type I IFN at the indicated time points prior‐ or postinfection. Cells were infected with normalized amounts of SARS–CoV‐2 wt (WT) or Nsp16mut at 0.015 RNA copies/cell. Viral load in the supernatant was quantified at 3 dpi by RT–qPCR targeting viral polymerase RdRp. Results are plotted as mean of triplicate infections with error bars representing the SD (biological replicates). One out of three independent experiments is shown ( n = 3). Data information: Statistical analysis was done using two‐way ANOVA followed by Bonferroni's multiple comparisons test. ns, not significant ( P > 0.05). Source data are available online for this figure.

Journal: EMBO Reports

Article Title: Nsp16 shields SARS–CoV ‐2 from efficient MDA5 sensing and IFIT1 ‐mediated restriction

doi: 10.15252/embr.202255648

Figure Lengend Snippet: Calu‐3 cells were incubated with the indicated amounts of type I IFN 24 h prior to infection with normalized amounts of SARS–CoV‐2 wt (WT) or Nsp16mut at 0.015 RNA copies/cell. Viral load in the supernatant was quantified at the indicated time points by RT–qPCR targeting viral polymerase RdRp. Results are plotted as mean of triplicate infections with error bars representing the SD (biological replicates). One out of three independent experiments is shown ( n = 3). Three days postinfection, protein expression of IFIT1 was analyzed by immunoblot to control for type I IFN treatment. Membranes were probed with antibodies targeting IFIT1 and the housekeeping gene HSP90. Calu‐3 cells were incubated with medium (‐IFN) or 100 U/well type I IFN at the indicated time points prior‐ or postinfection. Cells were infected with normalized amounts of SARS–CoV‐2 wt (WT) or Nsp16mut at 0.015 RNA copies/cell. Viral load in the supernatant was quantified at 3 dpi by RT–qPCR targeting viral polymerase RdRp. Results are plotted as mean of triplicate infections with error bars representing the SD (biological replicates). One out of three independent experiments is shown ( n = 3). Data information: Statistical analysis was done using two‐way ANOVA followed by Bonferroni's multiple comparisons test. ns, not significant ( P > 0.05). Source data are available online for this figure.

Article Snippet: Samples were separated by SDS–PAGE, transferred onto Immobilon‐P PVDF membranes (Merck), and probed with primary antibodies targeting endogenous IFIT‐1 (Cell Signaling, 14769), SARS–CoV2 Nucleocapsid protein (novubio, NB100‐56576), and the house keeping genes HSP90 α/β (Santa Cruz, sc‐13119) or GAPDH (Cell Signaling, 2118).

Techniques: Incubation, Infection, Quantitative RT-PCR, Expressing, Western Blot, Control

Expression of IFIT1 in the different Calu‐3 cell lines used in this study was analyzed by immunoblot. Membranes were probed with antibodies targeting IFIT1 and the housekeeping gene HSP90. Source data are available online for this figure.

Journal: EMBO Reports

Article Title: Nsp16 shields SARS–CoV ‐2 from efficient MDA5 sensing and IFIT1 ‐mediated restriction

doi: 10.15252/embr.202255648

Figure Lengend Snippet: Expression of IFIT1 in the different Calu‐3 cell lines used in this study was analyzed by immunoblot. Membranes were probed with antibodies targeting IFIT1 and the housekeeping gene HSP90. Source data are available online for this figure.

Article Snippet: Samples were separated by SDS–PAGE, transferred onto Immobilon‐P PVDF membranes (Merck), and probed with primary antibodies targeting endogenous IFIT‐1 (Cell Signaling, 14769), SARS–CoV2 Nucleocapsid protein (novubio, NB100‐56576), and the house keeping genes HSP90 α/β (Santa Cruz, sc‐13119) or GAPDH (Cell Signaling, 2118).

Techniques: Expressing, Western Blot

A549 luciferase KO (Ctrl) or IFIT1 KO cells were transduced with lentiviral particles encoding ACE2 followed by pretreatment with increasing amounts of type I IFN (IFNα2a) as indicated (10, 50, or 100 U/ml). At 24 h postinterferon treatment, cells were infected with SARS‐CoV‐2 wt or Nsp16mut at 0.025 RNA copies/cell. Virus release was quantified at 3 days postinfection by RT–qPCR targeting RdRp. Results are plotted as mean of triplicate infections with error bars representing the SD (biological repliactes). One out of three independent experiments is shown. Three days after SARS–CoV‐2 Nsp16mut infection of A549 cells described in (A), expression of IFIT1 and viral nucleocapsid protein N was analyzed by immunoblot. Membranes were probed with antibodies targeting IFIT1, SARS–CoV‐2 N protein, and the housekeeping gene HSP90. Calu‐3 control cells (Ctrl) or two different IFIT1 KO cell lines (IFIT1 KO #1, #2) were incubated with increasing amounts of type I IFN (10, 50, or 100 U/ml) 18 h prior to infection with SARS–CoV‐2 wt and Nsp16mut at 0.015 RNA copies/ml. Virus release was quantified at 3 dpi by RT–qPCR targeting RdRp. Results are plotted as mean of triplicate infections with error bars representing SD (biological replicates). One out of three independent experiments is shown. IFIT1 expression levels in Calu‐3 Ctrl, IFIT1 KO #1 and #2 lines treated with type I IFN (24 h; 100 U/ml) were analyzed by immunoblot. Membranes were probed with antibodies targeting IFIT1 or the housekeeping gene HSP90. A549 cells lacking IFIT1 (IFIT1 KO), the cellular methyltransferase MTR1 (MTR1 KO), both proteins (IFIT1/MTR1 KO), or control cells (Ctrl) were transduced with lentiviral particles encoding ACE2 and infected with SARS–CoV‐2 wt (WT) or Nsp16mut at 0.025 RNA copies/cell the next day. Virus release into the supernatant was quantified at the indicated time points by RT–qPCR. Results are plotted as mean of triplicate infections with error bars representing the SD. One out of three independent experiments is shown. Three days postinfection, A549 cells described in (E) were analyzed by immunoblot. Membranes were probed with antibodies targeting IFIT1, SARS–CoV‐2 N protein, or the housekeeping gene HSP90. A549 Ctrl and MTR1 KO cells were infected with SARS–CoV‐2 wt or Nsp16 mut virus at 0.015 RNA copies/cell or mock treated (triplicates, biological repeats). At 24 hpi, total RNA was extracted from lysed cells and expression of MxA and IFNβ transcripts was quantified using RT–qPCR. ISG levels were normalized on GAPDH transcripts. Data are plotted as mean of triplicate infections with error bars representing the SD. IFIT1 expression was analyzed in mock treated, SARS–CoV‐2 wt (WT) or Nsp16mut infected cells at 48 hpi by immunoblot. Membranes were probed with antibodies targeting IFIT1 and the housekeeping gene HSP90. Data information: Statistical analysis was performed using two‐way ANOVA followed by Bonferroni's multiple comparisons test. ns, not significant ( P > 0.05). Source data are available online for this figure.

Journal: EMBO Reports

Article Title: Nsp16 shields SARS–CoV ‐2 from efficient MDA5 sensing and IFIT1 ‐mediated restriction

doi: 10.15252/embr.202255648

Figure Lengend Snippet: A549 luciferase KO (Ctrl) or IFIT1 KO cells were transduced with lentiviral particles encoding ACE2 followed by pretreatment with increasing amounts of type I IFN (IFNα2a) as indicated (10, 50, or 100 U/ml). At 24 h postinterferon treatment, cells were infected with SARS‐CoV‐2 wt or Nsp16mut at 0.025 RNA copies/cell. Virus release was quantified at 3 days postinfection by RT–qPCR targeting RdRp. Results are plotted as mean of triplicate infections with error bars representing the SD (biological repliactes). One out of three independent experiments is shown. Three days after SARS–CoV‐2 Nsp16mut infection of A549 cells described in (A), expression of IFIT1 and viral nucleocapsid protein N was analyzed by immunoblot. Membranes were probed with antibodies targeting IFIT1, SARS–CoV‐2 N protein, and the housekeeping gene HSP90. Calu‐3 control cells (Ctrl) or two different IFIT1 KO cell lines (IFIT1 KO #1, #2) were incubated with increasing amounts of type I IFN (10, 50, or 100 U/ml) 18 h prior to infection with SARS–CoV‐2 wt and Nsp16mut at 0.015 RNA copies/ml. Virus release was quantified at 3 dpi by RT–qPCR targeting RdRp. Results are plotted as mean of triplicate infections with error bars representing SD (biological replicates). One out of three independent experiments is shown. IFIT1 expression levels in Calu‐3 Ctrl, IFIT1 KO #1 and #2 lines treated with type I IFN (24 h; 100 U/ml) were analyzed by immunoblot. Membranes were probed with antibodies targeting IFIT1 or the housekeeping gene HSP90. A549 cells lacking IFIT1 (IFIT1 KO), the cellular methyltransferase MTR1 (MTR1 KO), both proteins (IFIT1/MTR1 KO), or control cells (Ctrl) were transduced with lentiviral particles encoding ACE2 and infected with SARS–CoV‐2 wt (WT) or Nsp16mut at 0.025 RNA copies/cell the next day. Virus release into the supernatant was quantified at the indicated time points by RT–qPCR. Results are plotted as mean of triplicate infections with error bars representing the SD. One out of three independent experiments is shown. Three days postinfection, A549 cells described in (E) were analyzed by immunoblot. Membranes were probed with antibodies targeting IFIT1, SARS–CoV‐2 N protein, or the housekeeping gene HSP90. A549 Ctrl and MTR1 KO cells were infected with SARS–CoV‐2 wt or Nsp16 mut virus at 0.015 RNA copies/cell or mock treated (triplicates, biological repeats). At 24 hpi, total RNA was extracted from lysed cells and expression of MxA and IFNβ transcripts was quantified using RT–qPCR. ISG levels were normalized on GAPDH transcripts. Data are plotted as mean of triplicate infections with error bars representing the SD. IFIT1 expression was analyzed in mock treated, SARS–CoV‐2 wt (WT) or Nsp16mut infected cells at 48 hpi by immunoblot. Membranes were probed with antibodies targeting IFIT1 and the housekeeping gene HSP90. Data information: Statistical analysis was performed using two‐way ANOVA followed by Bonferroni's multiple comparisons test. ns, not significant ( P > 0.05). Source data are available online for this figure.

Article Snippet: Samples were separated by SDS–PAGE, transferred onto Immobilon‐P PVDF membranes (Merck), and probed with primary antibodies targeting endogenous IFIT‐1 (Cell Signaling, 14769), SARS–CoV2 Nucleocapsid protein (novubio, NB100‐56576), and the house keeping genes HSP90 α/β (Santa Cruz, sc‐13119) or GAPDH (Cell Signaling, 2118).

Techniques: Luciferase, Transduction, Infection, Virus, Quantitative RT-PCR, Expressing, Western Blot, Control, Incubation

Expression of MTR1 in the different A549 cell lines used in Fig was analyzed by immunoblot. Membranes were probed with antibodies targeting IFIT1 and the housekeeping gene HSP90. Source data are available online for this figure.

Journal: EMBO Reports

Article Title: Nsp16 shields SARS–CoV ‐2 from efficient MDA5 sensing and IFIT1 ‐mediated restriction

doi: 10.15252/embr.202255648

Figure Lengend Snippet: Expression of MTR1 in the different A549 cell lines used in Fig was analyzed by immunoblot. Membranes were probed with antibodies targeting IFIT1 and the housekeeping gene HSP90. Source data are available online for this figure.

Article Snippet: Samples were separated by SDS–PAGE, transferred onto Immobilon‐P PVDF membranes (Merck), and probed with primary antibodies targeting endogenous IFIT‐1 (Cell Signaling, 14769), SARS–CoV2 Nucleocapsid protein (novubio, NB100‐56576), and the house keeping genes HSP90 α/β (Santa Cruz, sc‐13119) or GAPDH (Cell Signaling, 2118).

Techniques: Expressing, Western Blot